1 – 31 of 31
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
(
- Contribution to journal › Scientific review
- 2022
-
Mark
A hydrophobic patch (PLVIVG; 1481–1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
(
- Contribution to journal › Article
- 2019
-
Mark
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
(
- Contribution to journal › Article
- 2017
-
Mark
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S
(
- Contribution to journal › Article
- 2005
-
Mark
Synthesis, Function, and Inactivation of Blood Coagulation Factor V.
(
- Thesis › Doctoral thesis (monograph)
-
Mark
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway. Novel Insights Into Structure-Function Relationships and Molecular Recognition.
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Altered inactivation pathway of factor Va by activated protein C in the presence of heparin
(
- Contribution to journal › Article
- 2003
-
Mark
Factor VI359T: a novel mutation associated with thrombosis and resistance to activated protein C
(
- Contribution to journal › Article
-
Mark
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
(
- Contribution to journal › Article
-
Mark
Structural and functional studies of factor V in health and disease
2003)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The regulation of factor Va activity by activated protein C -Importance of the individual activated protein C cleavage sites in factor Va
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Factor Va-factor Xa interactions: molecular sites involved in enzyme:cofactor assembly.
(
- Contribution to journal › Article
- 1999
-
Mark
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Anticoagulant protein C--structural and functional studies
1999)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Thrombophilia as a multigenic disease
(
- Contribution to journal › Article
- 1998
-
Mark
Pro- and anticoagulant activities of factor V
1998)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
(
- Contribution to journal › Letter
-
Mark
Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism
(
- Contribution to journal › Article
- 1997
-
Mark
The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance caused by a common factor V mutation has a single origin
(
- Contribution to journal › Article
-
Mark
The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance : Clinical implications
(
- Contribution to journal › Scientific review
-
Mark
Resistance to activated protein C a novel risk factor for venous thrombosis
1997)(
- Thesis › Doctoral thesis (compilation)
- 1996
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article
-
Mark
Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries
(
- Contribution to journal › Article
-
Mark
Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis
(
- Contribution to journal › Scientific review
-
Mark
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
- 1994
-
Mark
Myocardial infarction associated with homozygous resistance to activated protein C
(
- Contribution to journal › Letter
-
Mark
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
(
- Contribution to journal › Article
-
Mark
Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
(
- Contribution to journal › Article